ЛИТЕРАТУРА
1. National Asthma Education and Prevendon Program Expert Panel. Expat Panel No 2: Guidelines to the Diagnosis and Management of Asthma. Bethesda, MD: National Institute of Health/National Heart and Blood Institute. 1997. NIH Publication no 97-4051.
2. British Asthma Guidelines Co-ordinadng Committee. British guidelines on asthma management: 1995 review and position statement. Thorax 1997;52(Suppl):Sl-S24.
3. van Essen-Zandvlict ЕЕ, Hughes MD, Waalkens Ш, et al. Remission of childhood asthma after long-term treatment with an inhaled coiticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Rcspir J 1994;7:63-68.
4. Greening AP, Ind PW, Northfield M, Shaw G. Added salmet-erol versus higher-dose coiticosteroid in asthma patients with symptoms on existing inhaled coiticosteroid. Alien & Hanburys Limited UK Study Group. Lancet 1994;344:219-224.
5. Boyd G. Salmctcrol xinafoate in asthmatic patients under consideration for maintenance oral coiticosteroid therapy. Bur Respir J 1995;8:1494-1498.
6. Fauischou P. Steffensen I, Jacques L. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group. Eur Respir J 1996;9:1885-1890.
7. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled Steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
8. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Fonnot-erol And Corticosteroids Establishing Therapy (FACET) International Study Group. N Engi J Med 1997;337:1405-1411.
9. Russell G, Williams DA, Welter P, Price JF. Salmeterol xinafoate in children on Ugh dose inhaled steroids. Ann Allergy Asthma hnmunol 1995;75:423-428.
10. Meijer GG, Postma DS, Mulder PG, van Aalderen WM. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Am J Respir Crit Care Med 1995; 152:1887-1892.
11. Weinstein SF, Peariman OS, Bronsky EA, et al. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma. Ann Allergy Asthma Immunol 1998;81:51-58.
12. Lcnney W, Pedcrsen S, Boner AL, et al. Efficacy and safety of salmeterol in childhood asthma. Bur J Pediatr 1995,154: 983-090.
13. von Berg A, de Blic J, la Rosa M, et al. A comparison of regular Mimcterol vs 'as required' salbutamol therapy in asthmatic children. Respir Med 1998;92:292-299.
14. Zarkovic J, Goctz MH, Holgate ST. Taak NK. Effect of long-term regular salmeterol treatment in children with moderate asthma, din Drug Invest 1998;15:169-175.
15. American Thoracic Society (American Lung Association). Standard for the diagnosis and care of padents with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
16. Van Eitercn PH. On the combination of independent two-sample tests ofWilcoxon. Bull Int Stat Inst 1960;37:351-361.
17. US Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-94, Reference manuals and reports. Hyattsvillc, MD: Centers for Disease Control and Prevention, 1996.
Уважаемый посетитель!
Чтобы распечатать файл, скачайте его (в формате Word).
Ссылка на скачивание - внизу страницы.